Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May;39 Suppl 1(Suppl Suppl 1):143-155.
doi: 10.1111/liv.14089.

Surgery for cholangiocarcinoma

Affiliations
Review

Surgery for cholangiocarcinoma

Umberto Cillo et al. Liver Int. 2019 May.

Abstract

Surgical resection is the only potentially curative treatment for patients with cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic cholangiocarcinoma (iCCA), 5-year overall survival of about 30% has been reported in large series. This review addresses several challenges in surgical management of cholangiocarcinoma. The first challenge is diagnosis: a biopsy is typically avoided because of the risk of seeding metastases and the low yield of a brush of the bile duct. However, about 15% of patients with suspected pCCA are found to have a benign diagnosis after resection. The second challenge is staging; even with the best preoperative imaging, a substantial percentage of patients has occult metastatic disease detected at staging laparoscopy or early recurrence after resection. The third challenge is an adequate volume and function of the future liver remnant, which may require preoperative biliary drainage and portal vein embolization. The fourth challenge is a complete resection: a positive bile duct margin is not uncommon because the microscopic biliary extent of disease may be more extensive than perceived on imaging. The fifth challenge is the high post-operative mortality that has decreased in very high volume Asian centres, but remains about 10% in many Western referral centres. The sixth challenge is that even after a complete resection most patients develop recurrent disease. Recent randomized controlled trials found conflicting results regarding the benefit of adjuvant chemotherapy. The final challenge is to determine which patients with cholangiocarcinoma should undergo liver transplantation rather than resection.

Keywords: cholangiocarcinoma; hepatectomy; klatskin tumor; liver transplantation; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any disclosures to report.

Figures

Figure 1
Figure 1
(A) Resected specimen: extended right hemihepatectomy including segment I, extrahepatic bile duct, portal vein bifurcation and hilar tissue. Long suture at proximal cut end of left bile duct and forceps in resected portal vein bifurcation. (B) Lateral view of liver remnant (segments II, III and part of IV) after extended right hemihepatectomy with end‐to‐end anastomosis of the portal vein and transected left bile duct visible below left portal vein, prior to hepaticojejunostomy. (C) Anterior view of liver remnant (segments II, III and part of IV) after extended right hemihepatectomy

References

    1. AJCC Cancer Staging Manual ‐, 8th edn Springer; 2017:1032 pp.
    1. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512‐522. - PMC - PubMed
    1. Chaiteerakij R, Harmsen WS, Marrero CR, et al. A new clinically based staging system for perihilar cholangiocarcinoma. Am J Gastroenterol. 2014;109:1881‐1890. - PMC - PubMed
    1. Farges O, Regimbeau Jm, Fuks D, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100:274‐283. - PubMed
    1. Nuzzo G, Giuliante F, Ardito F, et al. Improvement in perioperative and long‐term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147:26‐34. - PubMed

Publication types